Implementation strategies are now needed to get polypills into the hands of more patients, particularly in poorer countries.

Cardiovascular disease (CVD) is responsible for up to 25% of premature deaths in the UK, 80% of which are preventable. We explore the role integrated care systems could play in scaling up the ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

AstraZeneca Vietnam has been honoured in the Outstanding CSR Activities category at the 2025 Top 50 Corporate Sustainability ...

Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...

People who have a stroke are more likely to die within a year if they live in more deprived areas according to new research ...

New research warns daily aspirin use in older adults without heart disease may do more harm than good, increasing bleeding risks despite outdated beliefs about its preventive benefits.

The findings from a contemporary US cohort point to the need for better ways to identify and treat those who are at risk.

AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...